Although the government is fighting the disease with intensive fumigation, elimination of breeding sites, and access to hospitals and medicines, the physician suggested to use of the vaccine, also known as Qdenga, developed by the Takeda laboratory and recommended by the World Health Organization (WHO).

As reported by an article in the Revista Disruptiva, of the Francisco Gavidia University, Panameño believes that given the current dengue situation, he sees in this vaccine a tool that can help in the fight against the disease and would complement other prevention measures such as the destruction of mosquito breeding sites, fumigation, and the delivery of pesticides.

To date, authorities have reported more than 500 contagions, and seven children were killed as a result of complications from the disease.

The vaccine should be administered to children aged four years and older, especially those living in areas with high dengue burden and transmission intensity, in a two-dose scheme with a three-month interval between doses, the expert said.

ef/iff/mem/lb